Results for "Revolution Medicines"

Keyword scan across titles, descriptions, summaries, and tags. For interview listings, try Guest appearances.

3 results

Episodes

  • Squawk on the Street
    Intelligent Report

    11AM Hour: Revolution Medicines CEO on Drug Approval, Nvidia Rallies on Earnings & Synopsys CEO 8/27/26

    Squawk on the Street· Aug 27, 2026

    Nvidia's blowout quarter dominates markets as analysts debate supply bottlenecks, vendor financing risks, and a $300 price target; plus FDA approves Revolution Medicines' pancreatic cancer pill and Fed hawks signal possi

    investing
  • Squawk on the Street
    StandardSummaries only

    11AM Hour: Kalshi CEO on Prediction Markets, Former Defense Secretary Mark Esper & Revolution Medicines CEO on Pancreatic Cancer Drug Breakthrough 6/1/26

    Squawk on the Street· Jun 1, 2026

    The CEO of Kalshi joins to discuss the company's latest product announcements and the regulatory environment for prediction markets. Then, Former Defense Secretary Mark Esper helps break down the latest headlines on the

    investing
  • Invest Like the Best with Patrick O'Shaughnessy
    StandardSummaries only

    Alex Karnal - The Trillion-Dollar Health Revolution

    Invest Like the Best with Patrick O'Shaughnessy· Apr 21, 2026

    My guest today is Alex Karnal. Alex is the co-founder and managing partner of Braidwell, a life sciences investment firm he built after spending 15 years at Deerfield Management. The frame we use throughout the episode i

    investing